HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Seppic comes to rescue of aging face, bust

This article was originally published in The Rose Sheet

Executive Summary

Noting that with age, "the cheeks become hollow and the chest sags," Paris-based subsidiary of Air Liquide introduces Voluform, a 3D "plumping" active ingredient it says can remodel curves of the face and bust, presenting an alternative to cosmetic surgery and Botox injections. Voluform stimulates "functionality" of adipocytes, or fat cells, and prevents loss of volume and fullness, according to information presented at in-cosmetics. "With its plumping effect, it redefines the contours of the face, fills in wrinkles and rounds out the chest with original tautness and firmness," Seppic says. After one month of topical treatment on the bust area, 83% of testers saw increased breast volume, while 60% recorded an average size increase of 0.6 centimeters. Firm is positioning Voluform as "an active ingredient for each generation.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel